Health Secretary Robert F. Kennedy Jr. plans to claim in a report expected this month from the Department of Health and Human Services that low levels of folate, an important vitamin, and Tylenol taken during pregnancy are potential causes of autism, people familiar with the matter told The Wall Street Journal’s Liz Essley Whyte and Nidhi Subbaraman. The Tylenol brand name is owned by McNeil Consumer Healthcare, a subsidiary of Kenvue (KVUE), which is down $1.87, or 9%, to $18.67 following the Journal’s report. Shares of Johnson & Johnson (JNJ), which previously spun out Kenvue, are down about 1%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- RFK Jr. to claim autism link to Tylenol use in pregnancy, WSJ reports
- Kenvue sinks after WSJ says RFK to link autism to Tylenol use
- Kenvue Inc put volume heavy and directionally bearish
- Third Point boosts position in Nvidia, takes new stakes in Mr Cooper, Meta
- Jeffrey Smith’s Starboard Value buys TripAdvisor in Q2